APO Research
Talk to an analyst

APO RESEARCH · REPORT

Teriflunomide API

Compare research editions
View pricing & licenses

Selected research

Industry Research

Teriflunomide API Industry Research Report 2026

27 December 2025144 pages

Choose your research edition.

Industry ResearchTeriflunomide API Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Teriflunomide API Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Teriflunomide API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Teriflunomide API Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Teriflunomide API Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Teriflunomide API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Teriflunomide API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Teriflunomide API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Teriflunomide API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Teriflunomide API include Alembic Pharma, Aurobindo Pharma, Camus Pharma, Clearsynth Labs, Dr. Reddy's Laboratories, Enaltec Labs, Honour Lab, Laurel Pharma Labs and Megafine Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Teriflunomide API market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Teriflunomide API Market by Company

Alembic Pharma

Aurobindo Pharma

Camus Pharma

Clearsynth Labs

Dr. Reddy's Laboratories

Enaltec Labs

Honour Lab

Laurel Pharma Labs

Megafine Pharma

MSN Laboratories

Natco Pharma

Par Chembio

Shilpa Pharma Lifesciences

Synzeal Research

Unichem Laboratories

VIVAN Life Sciences

Hangzhou Longshine Bio-Tech

Hefei Enrit Pharmaceutical

Jiangsu Yongan Pharmaceutical

Kivipharm

Nanjing Hengyang Pharmaceutical

Aurovitas Pharma Taizhou

Cinkate Pharmaceutical

Teriflunomide API Segment by Type

Purity≥98%

Purity≥99%

Teriflunomide API Segment by Application

Online Sales

Offline Sales

Teriflunomide API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Teriflunomide API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Teriflunomide API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Teriflunomide API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Teriflunomide API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Teriflunomide API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Teriflunomide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Teriflunomide API Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Teriflunomide API Sales (Tons) of Manufacturers (2021-2026) Table 7. Global Teriflunomide API Sales Market Share by Manufacturers (2021-2026) Table 8. Global Teriflunomide API Revenue of Manufacturers (2021-2026) Table 9. Global Teriflunomide API Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Teriflunomide API Average Price (US$/Ton) of Manufacturers (2021-2026) Table 11. Global Teriflunomide API Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Teriflunomide API, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Teriflunomide API, Product Type & Application Table 14. Global Teriflunomide API Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Teriflunomide API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Alembic Pharma Company Information Table 19. Alembic Pharma Business Overview Table 20. Alembic Pharma Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 21. Alembic Pharma Teriflunomide API Product Portfolio Table 22. Alembic Pharma Recent Developments Table 23. Aurobindo Pharma Company Information Table 24. Aurobindo Pharma Business Overview Table 25. Aurobindo Pharma Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 26. Aurobindo Pharma Teriflunomide API Product Portfolio Table 27. Aurobindo Pharma Recent Developments Table 28. Camus Pharma Company Information Table 29. Camus Pharma Business Overview Table 30. Camus Pharma Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 31. Camus Pharma Teriflunomide API Product Portfolio Table 32. Camus Pharma Recent Developments Table 33. Clearsynth Labs Company Information Table 34. Clearsynth Labs Business Overview Table 35. Clearsynth Labs Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 36. Clearsynth Labs Teriflunomide API Product Portfolio Table 37. Clearsynth Labs Recent Developments Table 38. Dr. Reddy's Laboratories Company Information Table 39. Dr. Reddy's Laboratories Business Overview Table 40. Dr. Reddy's Laboratories Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 41. Dr. Reddy's Laboratories Teriflunomide API Product Portfolio Table 42. Dr. Reddy's Laboratories Recent Developments Table 43. Enaltec Labs Company Information Table 44. Enaltec Labs Business Overview Table 45. Enaltec Labs Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Enaltec Labs Teriflunomide API Product Portfolio Table 47. Enaltec Labs Recent Developments Table 48. Honour Lab Company Information Table 49. Honour Lab Business Overview Table 50. Honour Lab Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 51. Honour Lab Teriflunomide API Product Portfolio Table 52. Honour Lab Recent Developments Table 53. Laurel Pharma Labs Company Information Table 54. Laurel Pharma Labs Business Overview Table 55. Laurel Pharma Labs Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 56. Laurel Pharma Labs Teriflunomide API Product Portfolio Table 57. Laurel Pharma Labs Recent Developments Table 58. Megafine Pharma Company Information Table 59. Megafine Pharma Business Overview Table 60. Megafine Pharma Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. Megafine Pharma Teriflunomide API Product Portfolio Table 62. Megafine Pharma Recent Developments Table 63. MSN Laboratories Company Information Table 64. MSN Laboratories Business Overview Table 65. MSN Laboratories Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. MSN Laboratories Teriflunomide API Product Portfolio Table 67. MSN Laboratories Recent Developments Table 68. Natco Pharma Company Information Table 69. Natco Pharma Business Overview Table 70. Natco Pharma Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Natco Pharma Teriflunomide API Product Portfolio Table 72. Natco Pharma Recent Developments Table 73. Par Chembio Company Information Table 74. Par Chembio Business Overview Table 75. Par Chembio Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Par Chembio Teriflunomide API Product Portfolio Table 77. Par Chembio Recent Developments Table 78. Shilpa Pharma Lifesciences Company Information Table 79. Shilpa Pharma Lifesciences Business Overview Table 80. Shilpa Pharma Lifesciences Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Shilpa Pharma Lifesciences Teriflunomide API Product Portfolio Table 82. Shilpa Pharma Lifesciences Recent Developments Table 83. Synzeal Research Company Information Table 84. Synzeal Research Business Overview Table 85. Synzeal Research Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Synzeal Research Teriflunomide API Product Portfolio Table 87. Synzeal Research Recent Developments Table 88. Unichem Laboratories Company Information Table 89. Unichem Laboratories Business Overview Table 90. Unichem Laboratories Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Unichem Laboratories Teriflunomide API Product Portfolio Table 92. Unichem Laboratories Recent Developments Table 93. VIVAN Life Sciences Company Information Table 94. VIVAN Life Sciences Business Overview Table 95. VIVAN Life Sciences Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. VIVAN Life Sciences Teriflunomide API Product Portfolio Table 97. VIVAN Life Sciences Recent Developments Table 98. Hangzhou Longshine Bio-Tech Company Information Table 99. Hangzhou Longshine Bio-Tech Business Overview Table 100. Hangzhou Longshine Bio-Tech Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Hangzhou Longshine Bio-Tech Teriflunomide API Product Portfolio Table 102. Hangzhou Longshine Bio-Tech Recent Developments Table 103. Hefei Enrit Pharmaceutical Company Information Table 104. Hefei Enrit Pharmaceutical Business Overview Table 105. Hefei Enrit Pharmaceutical Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Hefei Enrit Pharmaceutical Teriflunomide API Product Portfolio Table 107. Hefei Enrit Pharmaceutical Recent Developments Table 108. Jiangsu Yongan Pharmaceutical Company Information Table 109. Jiangsu Yongan Pharmaceutical Business Overview Table 110. Jiangsu Yongan Pharmaceutical Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Jiangsu Yongan Pharmaceutical Teriflunomide API Product Portfolio Table 112. Jiangsu Yongan Pharmaceutical Recent Developments Table 113. Kivipharm Company Information Table 114. Kivipharm Business Overview Table 115. Kivipharm Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Kivipharm Teriflunomide API Product Portfolio Table 117. Kivipharm Recent Developments Table 118. Nanjing Hengyang Pharmaceutical Company Information Table 119. Nanjing Hengyang Pharmaceutical Business Overview Table 120. Nanjing Hengyang Pharmaceutical Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Nanjing Hengyang Pharmaceutical Teriflunomide API Product Portfolio Table 122. Nanjing Hengyang Pharmaceutical Recent Developments Table 123. Aurovitas Pharma Taizhou Company Information Table 124. Aurovitas Pharma Taizhou Business Overview Table 125. Aurovitas Pharma Taizhou Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Aurovitas Pharma Taizhou Teriflunomide API Product Portfolio Table 127. Aurovitas Pharma Taizhou Recent Developments Table 128. Cinkate Pharmaceutical Company Information Table 129. Cinkate Pharmaceutical Business Overview Table 130. Cinkate Pharmaceutical Teriflunomide API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 131. Cinkate Pharmaceutical Teriflunomide API Product Portfolio Table 132. Cinkate Pharmaceutical Recent Developments Table 133. Global Teriflunomide API Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 134. Global Teriflunomide API Sales by Region (2021-2026) & (Tons) Table 135. Global Teriflunomide API Sales Market Share by Region (2021-2026) Table 136. Global Teriflunomide API Sales by Region (2027-2032) & (Tons) Table 137. Global Teriflunomide API Sales Market Share by Region (2027-2032) Table 138. Global Teriflunomide API Revenue by Region (2021-2026) & (US$ Million) Table 139. Global Teriflunomide API Revenue Market Share by Region (2021-2026) Table 140. Global Teriflunomide API Revenue by Region (2027-2032) & (US$ Million) Table 141. Global Teriflunomide API Revenue Market Share by Region (2027-2032) Table 142. North America Teriflunomide API Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. North America Teriflunomide API Sales by Country (2021-2026) & (Tons) Table 144. North America Teriflunomide API Sales by Country (2027-2032) & (Tons) Table 145. North America Teriflunomide API Revenue by Country (2021-2026) & (US$ Million) Table 146. North America Teriflunomide API Revenue by Country (2027-2032) & (US$ Million) Table 147. Europe Teriflunomide API Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Europe Teriflunomide API Sales by Country (2021-2026) & (Tons) Table 149. Europe Teriflunomide API Sales by Country (2027-2032) & (Tons) Table 150. Europe Teriflunomide API Revenue by Country (2021-2026) & (US$ Million) Table 151. Europe Teriflunomide API Revenue by Country (2027-2032) & (US$ Million) Table 152. Asia Pacific Teriflunomide API Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Asia Pacific Teriflunomide API Sales by Country (2021-2026) & (Tons) Table 154. Asia Pacific Teriflunomide API Sales by Country (2027-2032) & (Tons) Table 155. Asia Pacific Teriflunomide API Revenue by Country (2021-2026) & (US$ Million) Table 156. Asia Pacific Teriflunomide API Revenue by Country (2027-2032) & (US$ Million) Table 157. South America Teriflunomide API Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. South America Teriflunomide API Sales by Country (2021-2026) & (Tons) Table 159. South America Teriflunomide API Sales by Country (2027-2032) & (Tons) Table 160. South America Teriflunomide API Revenue by Country (2021-2026) & (US$ Million) Table 161. South America Teriflunomide API Revenue by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Teriflunomide API Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. Middle East and Africa Teriflunomide API Sales by Country (2021-2026) & (Tons) Table 164. Middle East and Africa Teriflunomide API Sales by Country (2027-2032) & (Tons) Table 165. Middle East and Africa Teriflunomide API Revenue by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Teriflunomide API Revenue by Country (2027-2032) & (US$ Million) Table 167. Global Teriflunomide API Sales by Type (2021-2026) & (Tons) Table 168. Global Teriflunomide API Sales by Type (2027-2032) & (Tons) Table 169. Global Teriflunomide API Sales Market Share by Type (2021-2026) Table 170. Global Teriflunomide API Sales Market Share by Type (2027-2032) Table 171. Global Teriflunomide API Revenue by Type (2021-2026) & (US$ Million) Table 172. Global Teriflunomide API Revenue by Type (2027-2032) & (US$ Million) Table 173. Global Teriflunomide API Revenue Market Share by Type (2021-2026) Table 174. Global Teriflunomide API Revenue Market Share by Type (2027-2032) Table 175. Global Teriflunomide API Price by Type (2021-2026) & (US$/Ton) Table 176. Global Teriflunomide API Price by Type (2027-2032) & (US$/Ton) Table 177. Global Teriflunomide API Sales by Application (2021-2026) & (Tons) Table 178. Global Teriflunomide API Sales by Application (2027-2032) & (Tons) Table 179. Global Teriflunomide API Sales Market Share by Application (2021-2026) Table 180. Global Teriflunomide API Sales Market Share by Application (2027-2032) Table 181. Global Teriflunomide API Revenue by Application (2021-2026) & (US$ Million) Table 182. Global Teriflunomide API Revenue by Application (2027-2032) & (US$ Million) Table 183. Global Teriflunomide API Revenue Market Share by Application (2021-2026) Table 184. Global Teriflunomide API Revenue Market Share by Application (2027-2032) Table 185. Global Teriflunomide API Price by Application (2021-2026) & (US$/Ton) Table 186. Global Teriflunomide API Price by Application (2027-2032) & (US$/Ton) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Teriflunomide API Distributors List Table 190. Teriflunomide API Customers List Table 191. Teriflunomide API Industry Trends Table 192. Teriflunomide API Industry Drivers Table 193. Teriflunomide API Industry Restraints Table 194. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Teriflunomide API Product Image Figure 5. Global Teriflunomide API Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Teriflunomide API Market Size (2021-2032) & (US$ Million) Figure 7. Global Teriflunomide API Sales (2021-2032) & (Tons) Figure 8. Global Teriflunomide API Average Price (US$/Ton) & (2021-2032) Figure 9. Purity≥98% Product Image Figure 10. Purity≥99% Product Image Figure 11. Online Sales Product Image Figure 12. Offline Sales Product Image Figure 13. Global Teriflunomide API Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Teriflunomide API, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Teriflunomide API Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Teriflunomide API Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Teriflunomide API Sales by Region in 2025 Figure 19. Global Teriflunomide API Revenue by Region in 2025 Figure 20. North America Teriflunomide API Market Size by Country in 2025 Figure 21. North America Teriflunomide API Sales Market Share by Country (2021-2032) Figure 22. North America Teriflunomide API Revenue Market Share by Country (2021-2032) Figure 23. United States Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Teriflunomide API Market Size by Country in 2025 Figure 27. Europe Teriflunomide API Sales Market Share by Country (2021-2032) Figure 28. Europe Teriflunomide API Revenue Market Share by Country (2021-2032) Figure 29. Germany Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Teriflunomide API Market Size by Country in 2025 Figure 40. Asia Pacific Teriflunomide API Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Teriflunomide API Revenue Market Share by Country (2021-2032) Figure 42. China Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Teriflunomide API Market Size by Country in 2025 Figure 51. South America Teriflunomide API Sales Market Share by Country (2021-2032) Figure 52. South America Teriflunomide API Revenue Market Share by Country (2021-2032) Figure 53. Brazil Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Teriflunomide API Market Size by Country in 2025 Figure 57. Middle East and Africa Teriflunomide API Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Teriflunomide API Revenue Market Share by Country (2021-2032) Figure 59. Egypt Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South Africa Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Israel Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Türkiye Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. GCC Countries Teriflunomide API Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Teriflunomide API Sales Market Share by Type (2021-2032) Figure 65. Global Teriflunomide API Revenue Market Share by Type (2021-2032) Figure 66. Global Teriflunomide API Price (US$/Ton) by Type (2021-2032) Figure 67. Global Teriflunomide API Sales Market Share by Application (2021-2032) Figure 68. Global Teriflunomide API Revenue Market Share by Application (2021-2032) Figure 69. Global Teriflunomide API Price (US$/Ton) by Application (2021-2032) Figure 70. Teriflunomide API Value Chain Figure 71. Teriflunomide API Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Teriflunomide API Industry Opportunities and Challenges

Scope & coverage.

Types
  • Purity≥98%
  • Purity≥99%
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Alembic Pharma
  • Aurobindo Pharma
  • Camus Pharma
  • Clearsynth Labs
  • Dr. Reddy's Laboratories
  • Enaltec Labs
  • Honour Lab
  • Laurel Pharma Labs
  • Megafine Pharma
  • MSN Laboratories
  • Natco Pharma
  • Par Chembio
  • Shilpa Pharma Lifesciences
  • Synzeal Research
  • Unichem Laboratories
  • VIVAN Life Sciences
  • Hangzhou Longshine Bio-Tech
  • Hefei Enrit Pharmaceutical
  • Jiangsu Yongan Pharmaceutical
  • Kivipharm
  • Nanjing Hengyang Pharmaceutical
  • Aurovitas Pharma Taizhou
  • Cinkate Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Teriflunomide API Market Size (2021-2032)
  4. 2.2.2 Global Teriflunomide API Sales (2021-2032)
  5. 2.2.3 Global Teriflunomide API Market Average Price (2021-2032)
  6. 2.3 Teriflunomide API by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Purity≥98%
  9. 2.3.3 Purity≥99%
  10. 2.4 Teriflunomide API by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Online Sales
  13. 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Teriflunomide API Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Teriflunomide API Sales (Tons) of Manufacturers (2021-2026)
  3. 3.3 Global Teriflunomide API Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Teriflunomide API Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Teriflunomide API Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Teriflunomide API, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Teriflunomide API, Product Type & Application
  8. 3.8 Global Manufacturers of Teriflunomide API, Established Date
  9. 3.9 Global Teriflunomide API Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Alembic Pharma
  2. 4.1.1 Alembic Pharma Company Information
  3. 4.1.2 Alembic Pharma Business Overview
  4. 4.1.3 Alembic Pharma Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Alembic Pharma Teriflunomide API Product Portfolio
  6. 4.1.5 Alembic Pharma Recent Developments
  7. 4.2 Aurobindo Pharma
  8. 4.2.1 Aurobindo Pharma Company Information
  9. 4.2.2 Aurobindo Pharma Business Overview
  10. 4.2.3 Aurobindo Pharma Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Aurobindo Pharma Teriflunomide API Product Portfolio
  12. 4.2.5 Aurobindo Pharma Recent Developments
  13. 4.3 Camus Pharma
  14. 4.3.1 Camus Pharma Company Information
  15. 4.3.2 Camus Pharma Business Overview
  16. 4.3.3 Camus Pharma Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Camus Pharma Teriflunomide API Product Portfolio
  18. 4.3.5 Camus Pharma Recent Developments
  19. 4.4 Clearsynth Labs
  20. 4.4.1 Clearsynth Labs Company Information
  21. 4.4.2 Clearsynth Labs Business Overview
  22. 4.4.3 Clearsynth Labs Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Clearsynth Labs Teriflunomide API Product Portfolio
  24. 4.4.5 Clearsynth Labs Recent Developments
  25. 4.5 Dr. Reddy's Laboratories
  26. 4.5.1 Dr. Reddy's Laboratories Company Information
  27. 4.5.2 Dr. Reddy's Laboratories Business Overview
  28. 4.5.3 Dr. Reddy's Laboratories Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Dr. Reddy's Laboratories Teriflunomide API Product Portfolio
  30. 4.5.5 Dr. Reddy's Laboratories Recent Developments
  31. 4.6 Enaltec Labs
  32. 4.6.1 Enaltec Labs Company Information
  33. 4.6.2 Enaltec Labs Business Overview
  34. 4.6.3 Enaltec Labs Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Enaltec Labs Teriflunomide API Product Portfolio
  36. 4.6.5 Enaltec Labs Recent Developments
  37. 4.7 Honour Lab
  38. 4.7.1 Honour Lab Company Information
  39. 4.7.2 Honour Lab Business Overview
  40. 4.7.3 Honour Lab Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Honour Lab Teriflunomide API Product Portfolio
  42. 4.7.5 Honour Lab Recent Developments
  43. 4.8 Laurel Pharma Labs
  44. 4.8.1 Laurel Pharma Labs Company Information
  45. 4.8.2 Laurel Pharma Labs Business Overview
  46. 4.8.3 Laurel Pharma Labs Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Laurel Pharma Labs Teriflunomide API Product Portfolio
  48. 4.8.5 Laurel Pharma Labs Recent Developments
  49. 4.9 Megafine Pharma
  50. 4.9.1 Megafine Pharma Company Information
  51. 4.9.2 Megafine Pharma Business Overview
  52. 4.9.3 Megafine Pharma Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Megafine Pharma Teriflunomide API Product Portfolio
  54. 4.9.5 Megafine Pharma Recent Developments
  55. 4.10 MSN Laboratories
  56. 4.10.1 MSN Laboratories Company Information
  57. 4.10.2 MSN Laboratories Business Overview
  58. 4.10.3 MSN Laboratories Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 MSN Laboratories Teriflunomide API Product Portfolio
  60. 4.10.5 MSN Laboratories Recent Developments
  61. 4.11 Natco Pharma
  62. 4.11.1 Natco Pharma Company Information
  63. 4.11.2 Natco Pharma Business Overview
  64. 4.11.3 Natco Pharma Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Natco Pharma Teriflunomide API Product Portfolio
  66. 4.11.5 Natco Pharma Recent Developments
  67. 4.12 Par Chembio
  68. 4.12.1 Par Chembio Company Information
  69. 4.12.2 Par Chembio Business Overview
  70. 4.12.3 Par Chembio Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Par Chembio Teriflunomide API Product Portfolio
  72. 4.12.5 Par Chembio Recent Developments
  73. 4.13 Shilpa Pharma Lifesciences
  74. 4.13.1 Shilpa Pharma Lifesciences Company Information
  75. 4.13.2 Shilpa Pharma Lifesciences Business Overview
  76. 4.13.3 Shilpa Pharma Lifesciences Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Shilpa Pharma Lifesciences Teriflunomide API Product Portfolio
  78. 4.13.5 Shilpa Pharma Lifesciences Recent Developments
  79. 4.14 Synzeal Research
  80. 4.14.1 Synzeal Research Company Information
  81. 4.14.2 Synzeal Research Business Overview
  82. 4.14.3 Synzeal Research Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Synzeal Research Teriflunomide API Product Portfolio
  84. 4.14.5 Synzeal Research Recent Developments
  85. 4.15 Unichem Laboratories
  86. 4.15.1 Unichem Laboratories Company Information
  87. 4.15.2 Unichem Laboratories Business Overview
  88. 4.15.3 Unichem Laboratories Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Unichem Laboratories Teriflunomide API Product Portfolio
  90. 4.15.5 Unichem Laboratories Recent Developments
  91. 4.16 VIVAN Life Sciences
  92. 4.16.1 VIVAN Life Sciences Company Information
  93. 4.16.2 VIVAN Life Sciences Business Overview
  94. 4.16.3 VIVAN Life Sciences Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 VIVAN Life Sciences Teriflunomide API Product Portfolio
  96. 4.16.5 VIVAN Life Sciences Recent Developments
  97. 4.17 Hangzhou Longshine Bio-Tech
  98. 4.17.1 Hangzhou Longshine Bio-Tech Company Information
  99. 4.17.2 Hangzhou Longshine Bio-Tech Business Overview
  100. 4.17.3 Hangzhou Longshine Bio-Tech Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Hangzhou Longshine Bio-Tech Teriflunomide API Product Portfolio
  102. 4.17.5 Hangzhou Longshine Bio-Tech Recent Developments
  103. 4.18 Hefei Enrit Pharmaceutical
  104. 4.18.1 Hefei Enrit Pharmaceutical Company Information
  105. 4.18.2 Hefei Enrit Pharmaceutical Business Overview
  106. 4.18.3 Hefei Enrit Pharmaceutical Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Hefei Enrit Pharmaceutical Teriflunomide API Product Portfolio
  108. 4.18.5 Hefei Enrit Pharmaceutical Recent Developments
  109. 4.19 Jiangsu Yongan Pharmaceutical
  110. 4.19.1 Jiangsu Yongan Pharmaceutical Company Information
  111. 4.19.2 Jiangsu Yongan Pharmaceutical Business Overview
  112. 4.19.3 Jiangsu Yongan Pharmaceutical Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Jiangsu Yongan Pharmaceutical Teriflunomide API Product Portfolio
  114. 4.19.5 Jiangsu Yongan Pharmaceutical Recent Developments
  115. 4.20 Kivipharm
  116. 4.20.1 Kivipharm Company Information
  117. 4.20.2 Kivipharm Business Overview
  118. 4.20.3 Kivipharm Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Kivipharm Teriflunomide API Product Portfolio
  120. 4.20.5 Kivipharm Recent Developments
  121. 4.21 Nanjing Hengyang Pharmaceutical
  122. 4.21.1 Nanjing Hengyang Pharmaceutical Company Information
  123. 4.21.2 Nanjing Hengyang Pharmaceutical Business Overview
  124. 4.21.3 Nanjing Hengyang Pharmaceutical Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Nanjing Hengyang Pharmaceutical Teriflunomide API Product Portfolio
  126. 4.21.5 Nanjing Hengyang Pharmaceutical Recent Developments
  127. 4.22 Aurovitas Pharma Taizhou
  128. 4.22.1 Aurovitas Pharma Taizhou Company Information
  129. 4.22.2 Aurovitas Pharma Taizhou Business Overview
  130. 4.22.3 Aurovitas Pharma Taizhou Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Aurovitas Pharma Taizhou Teriflunomide API Product Portfolio
  132. 4.22.5 Aurovitas Pharma Taizhou Recent Developments
  133. 4.23 Cinkate Pharmaceutical
  134. 4.23.1 Cinkate Pharmaceutical Company Information
  135. 4.23.2 Cinkate Pharmaceutical Business Overview
  136. 4.23.3 Cinkate Pharmaceutical Teriflunomide API Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Cinkate Pharmaceutical Teriflunomide API Product Portfolio
  138. 4.23.5 Cinkate Pharmaceutical Recent Developments
5 Global Teriflunomide API Market Scenario by Region
  1. 5.1 Global Teriflunomide API Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Teriflunomide API Sales by Region: 2021-2032
  3. 5.2.1 Global Teriflunomide API Sales by Region: 2021-2026
  4. 5.2.2 Global Teriflunomide API Sales by Region: 2027-2032
  5. 5.3 Global Teriflunomide API Revenue by Region: 2021-2032
  6. 5.3.1 Global Teriflunomide API Revenue by Region: 2021-2026
  7. 5.3.2 Global Teriflunomide API Revenue by Region: 2027-2032
  8. 5.4 North America Teriflunomide API Market Facts & Figures by Country
  9. 5.4.1 North America Teriflunomide API Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Teriflunomide API Sales by Country (2021-2032)
  11. 5.4.3 North America Teriflunomide API Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Teriflunomide API Market Facts & Figures by Country
  16. 5.5.1 Europe Teriflunomide API Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Teriflunomide API Sales by Country (2021-2032)
  18. 5.5.3 Europe Teriflunomide API Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Teriflunomide API Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Teriflunomide API Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Teriflunomide API Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Teriflunomide API Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Teriflunomide API Market Facts & Figures by Country
  41. 5.7.1 South America Teriflunomide API Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Teriflunomide API Sales by Country (2021-2032)
  43. 5.7.3 South America Teriflunomide API Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Teriflunomide API Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Teriflunomide API Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Teriflunomide API Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Teriflunomide API Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Teriflunomide API Sales by Type (2021-2032)
  2. 6.1.1 Global Teriflunomide API Sales by Type (2021-2032) & (Tons)
  3. 6.1.2 Global Teriflunomide API Sales Market Share by Type (2021-2032)
  4. 6.2 Global Teriflunomide API Revenue by Type (2021-2032)
  5. 6.2.1 Global Teriflunomide API Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Teriflunomide API Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Teriflunomide API Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Teriflunomide API Sales by Application (2021-2032)
  2. 7.1.1 Global Teriflunomide API Sales by Application (2021-2032) & (Tons)
  3. 7.1.2 Global Teriflunomide API Sales Market Share by Application (2021-2032)
  4. 7.2 Global Teriflunomide API Revenue by Application (2021-2032)
  5. 7.2.1 Global Teriflunomide API Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Teriflunomide API Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Teriflunomide API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Teriflunomide API Value Chain Analysis
  2. 8.1.1 Teriflunomide API Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Teriflunomide API Production Mode & Process
  5. 8.2 Teriflunomide API Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Teriflunomide API Distributors
  8. 8.2.3 Teriflunomide API Customers
9 Global Teriflunomide API Analyzing Market Dynamics
  1. 9.1 Teriflunomide API Industry Trends
  2. 9.2 Teriflunomide API Industry Drivers
  3. 9.3 Teriflunomide API Industry Opportunities and Challenges
  4. 9.4 Teriflunomide API Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst